🇺🇸 FDA
Pipeline program

rhTPO

XJTU1AF2018LSK-056

Approved small_molecule active

Quick answer

rhTPO for Thrombocytopenia is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Thrombocytopenia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials